Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Reptile scales help us understand the evolution of skin features like hair and feathers.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

Injectable Platelet Rich Fibrin effectively improves hair growth in males with hair loss.

Certain genes influence the direction of hair whorls on the scalp.

Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Hospital staff have a higher rate of hair loss than the general population.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Oral minoxidil may be a better treatment for hair loss than topical minoxidil.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.